SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Five desalination plants are struggling. Israel won't say how it is making up the difference

Zuckerberg rejects calls for AI industry-wide slowdown

Israel's 1.5% inflation rate may be more mirage than reality

Israel spent $75.7 billion on the war through 2025, with costs set to persist for years

Buzz

Most popular

Daily

Weekly

1

Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction

2

Oracle’s AI transformation gets more expensive as layoffs continue

3

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

4

OpenAI acquires Israeli-founded camera startup Glass Imaging for over $300 million

5

Oracle begins another round of layoffs as $2.8 billion restructuring plan expands

Clinical Trials

5 stories about Clinical Trials

בניין חברת טבע כפר סבא

Teva moves closer to a drug for celiac disease with positive Phase 2 results

02.09.26|Sophie Shulman

The company's TEV-408 antibody met its primary endpoint in a 50-patient trial and reduced intestinal damage, inflammation and gastrointestinal symptoms. Teva is also advancing the treatment for vitiligo, potentially expanding the commercial opportunity for the same drug.

rewalk רובוטיקה שלד חיצוני

ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit

04.04.18|Asaf Shalev

After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators

Company that Develops Injectable Bone Grafts Expands Clinical Trial

12.03.18|Dror Reich

Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure

Bonus Biogroup Says First Lab-Grown Leg Bone Transplanted in Patient

21.12.17|Lilach Baumer

The Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection

MeMed מכשיר לזיהוי זיהום ב דם

Automated Medical Diagnosis Startup Raises $30 Million

19.09.17|Omer Kabir

Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense